Skip to main content

Table 3 Schedule of assessments

From: Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

  Baseline 4-6 wks 4 mth 8 mth 12 mth 16 mth 20 mth 24 mth
History X   X X X X X X
Body mass index/height cm X   X X X X X X
Serum corrected calcium X X X X X X X X
Phosphate X X X X X X X X
24 hour urinary calcium (preferred) X X X      
Urinary calcium/creatinine ratio
(for first 3 time points only if 24 h urine unavailable)
X X X X X X X X
Serum
25O D
X X X   X    X
FBC X    X   X   X
LFTs X    X   X   X
eGFR X    X   X   X
Adherence to dosing regime X   X X X X X X
Tumour status X   X X X X X X
  1. Note: Serum corrected calcium requires serum albumin.